Zoetis Inc(NYSE:ZTS) Declares Dividend of $0.0950.

Zoetis Inc (NYSE:ZTS) had declared a cash dividend of $0.0950 on Oct 6, 2016. The shares will quote ex-dividend on Nov 1, 2016 and the record date has been fixed for Nov 3, 2016. On Oct 6, 2016 share price, the yield comes out to be 0.7357%. The dividend payable date has been fixed on Dec 1, 2016.

In a different note, Bank of America said it Initiates Coverage on Zoetis Inc, according to a research note issued on Sep 29, 2016. The shares have been rated ‘Buy’ by the firm. On Sep 9, 2016, Argus Research said it Maintains its rating on Zoetis Inc. In the research note, the firm Raises the price-target to $54.00 per share. The shares have been rated ‘Below Average’ by the firm. On Aug 4, 2016, Barclays said it Maintains its rating on Zoetis Inc. In the research note, the firm Raises the price-target to $45.00 per share. The shares have been rated ‘Equal-weight’ by the firm. On Aug 4, 2016, Citigroup said it Maintains its rating on Zoetis Inc. In the research note, the firm Raises the price-target to $50.00 per share. The shares have been rated ‘Neutral’ by the firm. On Aug 4, 2016, Jefferies said it Maintains its rating on Zoetis Inc. In the research note, the firm Raises the price-target to $58.00 per share. The shares have been rated ‘Buy’ by the firm.

Zoetis Inc (ZTS) shares turned negative on Fridays trading session with the shares closing down -0.84 points or -1.65% at a volume of 24,85,377. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $51.165. The peak price level was also seen at $51.165 while the days lowest was $50.18. Finally the shares closed at $50.18. The 52-week high of the shares is $53.14 while the 52-week low is $38.26. According to the latest information available, the market cap of the company is $24,841 M.

Zoetis Inc(ZTS) last announced its earnings results on Aug 3, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $1.21B. Analysts had an estimated revenue of $1.17B. Earnings per share were $0.49. Analysts had estimated an EPS of $0.44.

Several Insider Transactions has been reported to the SEC. On Sep 6, 2016, Michael B Mccallister (director) purchased 2,000 shares at $51.34 per share price.Also, On Sep 2, 2016, Andrew Fenton (Executive Vice President) sold 13,870 shares at $51.25 per share price.On Sep 2, 2016, Heidi C. Chen (Executive Vice President) sold 32,097 shares at $50.98 per share price, according to the Form-4 filing with the securities and exchange commission.

Zoetis Inc. is engaged in the discovery development manufacture and commercialization of animal health medicines and vaccines with a focus on both livestock and companion animals. The Company markets products across four regions: the United States Europe/Africa/Middle East Canada/Latin America and Asia/Pacific; eight species: the livestock species of cattle swine poultry sheep and fish and the companion animal species of dogs cats and horses and five product categories: anti-infectives vaccines parasiticides medicated feed additives and other pharmaceutical products. In addition its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Zoetis Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zoetis Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.